FutureWorld in brief
FutureWorld is a listed company in the Biotechnology industry, based in St. Petersburg, USA. In the year to March 2015 it had sales of $0 M and a net loss of $2 M. Its shares trade under the symbol FWDG (OTC Markets Group).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About FutureWorld
The address of our executive offices is: 10901 Roosevelt Blvd, Suite 1000c, Saint Petersburg, FL 33716 and our telephone number at that address is 727-474-1816. The address of our web site is www.futureworldcorp.com. The information at our web site is for general information and marketing purposes and is not part of this annual report for purposes of liability for disclosures under the federal securities laws.
FutureWorld (FWDG), a Delaware corporation, is a leading provider of advanced technologies and solutions to the global cannabis industry. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products and services, such as industrial Hemp. FutureWorld, through its subsidiaries, provides personal and professional THC and CBD test kits, pharmaceutical grade CBD oil solutions, SafeVape vaporizers, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana.
From the company's annual report filed with the US SEC: read the report
FutureWorld timeline
- 2004
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2009
- ✎Renamed Futureworld Energy, Inc.Formerly Hathaway Corp.
- 2014
- ✎Renamed Futureworld Corp.Formerly Futureworld Energy, Inc..
Events of FutureWorld from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
Not enough history yet.
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin (TTM)
- -1722.2%
- Operating margin
- -1177.8%
- Return on equity
- —
- Liabilities / assets
- 351.5%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Mar 2015 | $0M | — | $-1M | $-2M | -1722.2% |
| Mar 2014 | — | — | $-0M | $-0M | — |
| Mar 2013 | — | — | $-0M | $-0M | — |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Mar 2015 | $-1M | $0M | $-1M | $-0.00 | — |
| Mar 2014 | $-0M | — | — | $-0.00 | — |
| Mar 2013 | — | — | — | $0.00 | — |
SEC filings
- Aug 18, 20178-KCurrent reportOther events
- Apr 5, 201710-K/AAnnual report (amended) · period to Mar 2016
- Feb 14, 201710-QQuarterly report · period to Dec 2016
- Nov 21, 201610-QQuarterly report · period to Sep 2016
- Aug 23, 201610-QQuarterly report · period to Jun 2016
- Jul 21, 20168-KCurrent reportDirectors or officers changed
- Jul 14, 201610-KAnnual report · period to Mar 2016
- Jun 14, 20168-KCurrent reportOther events
- May 31, 201610-K/AAnnual report (amended) · period to Mar 2015
- May 26, 20168-KCurrent reportDirectors or officers changed
- Mar 14, 20168-KCurrent reportAcquisition or disposal completed
- Mar 2, 201610-QQuarterly report · period to Dec 2015
Official filings of FutureWorld with the US Securities and Exchange Commission.
Annual results
- Revenue
- $0 M
- Operating income
- $-1 M
- Net income
- $-2 M
For year ending March-2015 · source: SEC filing
Balance sheet
- Total assets
- $0 M
- Total liabilities
- $1 M
- Total equity
- $-1 M
As of March-2015
Insider trading at FutureWorld#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Futureworld Corp.CEO, Director, 10% owner | Buy | +3.51 M | — | — | 9.04 M | Form 4 |
| filed | Futureworld Corp.CEO, Director, 10% owner | Buy | +1.12 M | — | — | 5.53 M | Form 4 |
| filed | Futureworld Corp.CEO, Director, 10% owner | Buy | +1.92 M | — | — | 4.41 M | Form 4 |
| filed | Futureworld Corp.CEO, Director, 10% owner | Buy | +1.49 M | $0.010 | $15 K | 2.49 M | Form 4 |
| filed | Futureworld Corp.CEO, Director, 10% owner | Buy | +448,100 | $0.030 | $13 K | 1.00 M | Form 4 |
| filed | Futureworld Corp.CEO | Buy | +204,299 | $0.030 | $6 K | 554,448 | Form 4 |
| filed | Futureworld Energy, Inc..CEO, Director | Grant or award | +201,448 | $0.030 | $6 K | 501,448 | Form 4 |
| filed | Futureworld Energy, Inc..CEO, 10% owner | Buy | +350,000 | $0.020 | $7 K | 146.70 M | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
FutureWorld scorecard#
Passes 0 of the 5 checks that could be worked out. Fiscal year 2014.
Valuationnot known
- –P/E below its peers' medianNo market cap.
- –Price to book below its peers' medianNo market cap.
- –Price to sales below its peers' medianNo market cap.
- –Free cash flow yield above 5%No market cap.
- –Earnings yield above the 10-year Treasury yieldNo market cap.
- –The price assumes slower growth than the last three years'No market cap.
Growth0 of 1
- –Revenue grew in the newest yearRevenue of the year before is not on file.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- ✗Earnings per share grew in the newest year-0.00 vs -0.00Diluted EPS -0.00 in fiscal 2014 against -0.00 the year before (report's currency).
- –Net income higher than five years earlierNet income of five years earlier is not on file.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability0 of 1
- ✗Profitable in the newest year-$2 MNet income -$2 M in fiscal 2014.
- –Profitable in each of the last five yearsFive years of net income are not on file.
- –Operating margin above its peers' medianNo operating margin on file.
- –Return on equity above 15%No return on equity (equity missing or negative).
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial health0 of 2
- ✗Short-term assets cover short-term liabilities0.2×Current ratio 0.22 at the end of fiscal 2014.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- ✗Operating income covers interest five times-2.2×Operating income -2.2 times interest in fiscal 2014.
- –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year70.5%Diluted shares up 70.5% in fiscal 2014.
- –Dividends and buybacks above 3% of the market valueNo market cap.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
FutureWorld: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2014to Mar 31, 2015 | FY 2013to Mar 31, 2014 | FY 2012to Mar 31, 2013 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 90r54—100% | — | — | |
| Cost of revenue | 49—54.1% | — | — | |
| Operating expenses | −1,097r1,029−873%−1219% | 142+37.4%— | 103—— | |
| Operating income | −1,056r−975—−1173% | −142—— | −103—— | |
| Interest expense and finance costs | 493r423+3323%548% | 14−3.6%— | 15—— | |
| Other non-operating income (expense) | −493r−430—−548% | −14—— | −15—— | |
| Net income attributable to shareholders | −1,549r−1,405—−1721% | −156—— | −118—— | |
| Earnings per share, basic | 0.00r-0.00—— | 0.00r0.00−100%— | 0.00—— | |
| Earnings per share, diluted | -0.00—— | -0.00r0.00−233%— | 0.00—— | |
| Shares, weighted average (basic) | 479+11.5%— | 429+3.1%— | 416—— | |
| Shares, weighted average (diluted) | 732+70.4%— | 429+3.1%— | 416—— | |
| Balance sheet | ||||
| Cash and cash equivalents | 3.7r3.7+85.8%1.1% | 2.0−99.2%100% | 245—— | |
| Receivables | 154r383—46.2% | 0—0.0% | — | |
| Inventory | 77r48—22.9% | 0—0.0% | — | |
| Current assets | 233r435+11561%69.9% | 2.0—100% | — | |
| Property, plant and equipment | 3.9—1.2% | — | — | |
| Other intangible assets | 1.7r1.7—0.5% | — | — | |
| Total assets | 334r35,385+16592%100% | 2.0—100% | — | |
| Accounts payable | 30r26+379%9.1% | 6.4—318% | — | |
| Current liabilities | 1,029r1,554−6.1%308% | 1,096r1,096+15.9%54794% | 946—— | |
| Non-current liabilities | 129r113−53.4%38.7% | 277−7.3%13867% | 299—— | |
| Total liabilities | 1,159r1,667−15.6%347% | 1,373+10.3%68661% | 1,245—— | |
| Retained earnings | −7,613r−7,469—−2280% | −6,063—−303171% | −5,907—— | |
| Shareholders' equity | −825r33,718—−247% | −1,371—−68561% | −1,245—— | |
| Total liabilities and equity | 334r35,385+16592%100% | 2.0—100% | — | |
| Shares outstanding | 732+63.9%— | 446r446+7.2%— | 416—— | |
| Cash-flow statement | ||||
| Depreciation and amortization | 7.3r43—8.1% | — | — | |
| Share-based compensation | 109—121% | — | — | |
| Cash from operating activities | −781r−716—−867% | −6.2—— | — | |
| Capital expenditure | −64—−70.8% | — | — | |
| Intangible assets bought | −1.7—−1.9% | — | — | |
| Cash from investing activities | −1.7r−65—−1.9% | — | — | |
| Debt issued | 904—1004% | 0—— | — | |
| Cash from financing activities | 783r783+9421%869% | 8.2—— | — | |
| Change in cash | 0.3r1.7−83.5%0.4% | 2.0—— | — | |
| Report | 10-K/A | 10-K/A | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Mar 31, 2015 | Q4 FY2014to Mar 31, 2015 | Q3 FY2014to Dec 31, 2014 | Q2 FY2014to Sep 30, 2014 | Q1 FY2014to Jun 30, 2014 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | — | — | 362—100% | 77—100% | 0.3—100% | |
| Cost of revenue | — | — | 6.8—1.9% | 37—48.2% | 0.2—58.9% | |
| Gross profit | — | — | 356—98.1% | 40—51.8% | 0.1—41.1% | |
| General and administrative | — | — | 199—54.9% | 56—72.0% | 15—4833% | |
| Operating expenses | — | — | 480—132% | 342—442% | 174—56172% | |
| Interest expense and finance costs | 473—— | 282r212*—— | 44—12.1% | 142—184% | 5.3—1716% | |
| Other non-operating income (expense) | −473—— | −282r−219*—— | −44—−12.1% | −142—−184% | −5.3—−1716% | |
| Income before tax | — | — | −168—−46.4% | −444—−574% | −179—−57887% | |
| Income tax | — | — | 0—0.0% | 0—0.0% | — | |
| Net income including minority interests | — | — | −168—−46.4% | — | — | |
| Minority interests' share of net income | — | — | 0—0.0% | 0—0.0% | — | |
| Net income attributable to shareholders | −1,524—— | −733r−589*—— | −168—−46.4% | −444—−574% | −179—−57887% | |
| Earnings per share, basic | — | — | 0.00—— | 0.00—— | 0.00—— | |
| Shares, weighted average (basic) | — | — | 466—— | 453—— | 501—— | |
| Balance sheet | ||||||
| Cash and cash equivalents | 3.7—1.1% | 3.7r3.7—1.1% | 151—16.9% | 286—54.6% | 133—46.3% | |
| Receivables | 154—46.2% | 154r383—46.2% | 544—61.1% | 73—13.9% | 0.1—0.0% | |
| Inventory | 77—22.9% | 77r48—22.9% | 38—4.3% | 3.5—0.7% | 11—4.0% | |
| Current assets | 233—69.9% | 233r435—69.9% | 733—82.3% | 423—80.8% | 185—64.2% | |
| Property, plant and equipment | 3.9—1.2% | 3.9—1.2% | 1.0—0.1% | 0—0.0% | — | |
| Other intangible assets | 1.7—0.5% | 1.7r1.7—0.5% | 94—10.6% | 98—18.7% | 101—35.0% | |
| Total assets | 334—100% | 334r35,385—100% | 890—100% | 523—100% | 288—100% | |
| Accounts payable | 30—9.1% | 30r26—9.1% | 47—5.3% | 21—4.0% | 0.9—0.3% | |
| Current liabilities | 1,029—308% | 1,029r1,554—308% | 2,050—230% | 1,772—339% | 1,270—441% | |
| Non-current liabilities | 129—38.7% | 129r113—38.7% | — | — | — | |
| Total liabilities | 1,159—347% | 1,159r1,667—347% | 2,050—230% | 1,772—339% | 1,494—519% | |
| Retained earnings | −7,613—−2280% | −7,613r−7,469—−2280% | — | — | — | |
| Shareholders' equity | −825—−247% | −825r33,718—−247% | −1,160—−130% | −1,249—−239% | −1,206—−419% | |
| Minority interests | — | — | 0—0.0% | 0—0.0% | — | |
| Total liabilities and equity | 334—100% | 334r35,385—100% | 890—100% | 523—100% | 288—100% | |
| Shares outstanding | 732—— | 732—— | 454—— | 454—— | 501—— | |
| Cash-flow statement | ||||||
| Depreciation and amortization | — | — | 112—31.0% | 1.4—1.8% | 20—6435% | |
| Share-based compensation | — | — | 13*—3.5% | — | — | |
| Cash from operating activities | −781—— | −71r−6.6*—— | −296*—−81.6% | −290*—−374% | −124—−40131% | |
| Cash from investing activities | — | 0.5r−63*—— | −1.4*—−0.4% | — | — | |
| Debt issued | 904—— | −45*—— | 179*—49.4% | 691*—891% | 79—25717% | |
| Shares issued | — | — | — | — | −101—−32629% | |
| Cash from financing activities | 783—— | −78r−77*—— | 162*—44.8% | 443*—572% | 255—82668% | |
| Change in cash | 0.3—— | −148r−147*—— | −135*—−37.2% | 152*—197% | 131—42537% | |
| Report | Worked out | 10-K/A | 10-Q | 10-Q | 10-Q/A | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Mar 31, 2015. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Events at FutureWorld#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Auditor changed 2 · Acquisition or sale completed 4 · Directors and officers 4 · Material agreement 2
| Filed | What happened | Filing |
|---|---|---|
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Acquisition or sale completed | 8-K | |
| Material agreement | 8-K | |
| Acquisition or sale completed | 8-K | |
| Material agreement | 8-K | |
| Auditor changed | 8-K | |
| Auditor changed | 8-K | |
| Acquisition or sale completed | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Acquisition or sale completed | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Jul 21, 2016
How FutureWorld compares in Biotechnology
- Revenue$0 M · higher than 16% of 647
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| FutureWorld🇺🇸 | — | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Annual results:
- For year ending March-2015
- Balance sheet:
- As of March-2015
- Profile updated:
- Nov 16, 2026
Figures from SEC filing, Wikidata, SEC annual report, value.today research; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at FutureWorld? Verify and update this profile — free
Show FutureWorld's ranking on your website Get the badge
The badge updates itself as the ranking changes.